RGNX – REGENXBIO Inc.
RGNX — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
14.69
Margin Of Safety %
Put/Call OI Ratio
0.41
EPS Next Q Diff
0.75
EPS Last/This Y
0.97
EPS This/Next Y
0.25
Price
10.73
Target Price
26.5
Analyst Recom
1.5
Performance Q
Upside
-1,337.4%
Beta
0.96
Ticker: RGNX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | RGNX | 12.76 | 0.19 | 1.27 | 13153 |
| 2026-07-14 | RGNX | 12.29 | 0.21 | 0.10 | 13545 |
| 2026-07-15 | RGNX | 12.28 | 0.21 | 0.63 | 13664 |
| 2026-07-16 | RGNX | 11.2 | 0.21 | 0.22 | 13695 |
| 2026-07-17 | RGNX | 9.88 | 0.21 | 0.98 | 13732 |
| 2026-07-20 | RGNX | 10.31 | 0.61 | 0.01 | 5499 |
| 2026-07-21 | RGNX | 10.33 | 0.51 | 1.15 | 6253 |
| 2026-07-22 | RGNX | 10.2 | 0.54 | 0.44 | 6661 |
| 2026-07-23 | RGNX | 10.24 | 0.54 | 0.29 | 6725 |
| 2026-07-24 | RGNX | 9.73 | 0.54 | 0.75 | 6730 |
| 2026-07-27 | RGNX | 9.69 | 0.58 | 1.11 | 6892 |
| 2026-07-28 | RGNX | 9.59 | 0.58 | 1.26 | 6927 |
| 2026-07-29 | RGNX | 9.61 | 0.58 | 4.33 | 6911 |
| 2026-07-30 | RGNX | 10.12 | 0.58 | 0.00 | 6916 |
| 2026-07-31 | RGNX | 9.68 | 0.43 | 0.18 | 8461 |
| 2026-08-03 | RGNX | 9.96 | 0.43 | 0.25 | 8574 |
| 2026-08-04 | RGNX | 10.3 | 0.43 | 0.00 | 8582 |
| 2026-08-05 | RGNX | 10.49 | 0.43 | 0.14 | 8490 |
| 2026-08-06 | RGNX | 11.27 | 0.43 | 0.06 | 8524 |
| 2026-08-07 | RGNX | 10.71 | 0.41 | 1.43 | 8799 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | RGNX | 12.76 | 108.7 | - | -2.82 |
| 2026-07-14 | RGNX | 12.31 | 108.7 | - | -2.82 |
| 2026-07-15 | RGNX | 12.28 | 108.7 | - | -2.82 |
| 2026-07-16 | RGNX | 11.20 | 108.7 | - | -2.82 |
| 2026-07-17 | RGNX | 9.86 | 108.7 | - | -2.82 |
| 2026-07-20 | RGNX | 10.31 | 108.7 | - | -2.82 |
| 2026-07-21 | RGNX | 10.33 | 108.7 | - | -2.82 |
| 2026-07-22 | RGNX | 10.20 | 108.7 | - | -2.82 |
| 2026-07-23 | RGNX | 10.23 | 108.7 | - | -2.82 |
| 2026-07-24 | RGNX | 9.73 | 92.2 | - | -2.79 |
| 2026-07-27 | RGNX | 9.69 | 92.2 | - | -2.79 |
| 2026-07-28 | RGNX | 9.59 | 92.2 | - | -2.79 |
| 2026-07-29 | RGNX | 9.60 | 92.2 | - | -2.79 |
| 2026-07-30 | RGNX | 10.10 | 92.2 | - | -2.79 |
| 2026-07-31 | RGNX | 9.69 | 92.2 | - | -2.79 |
| 2026-08-03 | RGNX | 9.97 | 92.2 | - | -2.79 |
| 2026-08-04 | RGNX | 9.97 | 92.2 | - | -2.79 |
| 2026-08-05 | RGNX | 10.48 | 92.2 | - | -2.79 |
| 2026-08-06 | RGNX | 11.27 | 92.2 | - | -2.79 |
| 2026-08-07 | RGNX | 10.73 | 92.2 | - | -2.79 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | RGNX | -1.57 | -1.14 | 22.51 |
| 2026-07-14 | RGNX | -1.49 | -1.14 | 22.51 |
| 2026-07-15 | RGNX | -1.49 | -1.14 | 22.51 |
| 2026-07-16 | RGNX | -1.49 | -1.14 | 22.51 |
| 2026-07-17 | RGNX | -1.49 | -1.14 | 22.51 |
| 2026-07-20 | RGNX | -1.49 | -1.91 | 22.51 |
| 2026-07-21 | RGNX | -1.49 | -1.91 | 22.51 |
| 2026-07-22 | RGNX | -1.49 | -1.91 | 22.51 |
| 2026-07-23 | RGNX | -1.49 | -1.91 | 22.51 |
| 2026-07-24 | RGNX | -1.49 | -1.91 | 22.51 |
| 2026-07-27 | RGNX | -1.18 | -1.60 | 0 |
| 2026-07-28 | RGNX | -1.18 | -1.60 | 15.55 |
| 2026-07-29 | RGNX | -1.18 | -1.60 | 14.69 |
| 2026-07-30 | RGNX | -1.18 | -1.60 | 14.69 |
| 2026-07-31 | RGNX | -1.18 | -1.60 | 14.69 |
| 2026-08-03 | RGNX | -1.18 | -1.77 | 14.69 |
| 2026-08-04 | RGNX | -1.18 | -1.77 | 14.69 |
| 2026-08-06 | RGNX | -1.18 | -1.77 | 14.69 |
| 2026-08-07 | RGNX | -1.18 | -1.77 | 14.69 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.72
Avg. EPS Est. Current Quarter
-0.11
Avg. EPS Est. Next Quarter
-0.97
Insider Transactions
-1.18
Institutional Transactions
-1.77
Beta
0.96
Average Sales Estimate Current Quarter
106
Average Sales Estimate Next Quarter
45
Fair Value
Quality Score
28
Growth Score
29
Sentiment Score
50
Actual DrawDown %
76.9
Max Drawdown 5-Year %
-88.4
Target Price
26.5
P/E
Forward P/E
PEG
P/S
4.01
P/B
8.09
P/Free Cash Flow
EPS
-3.79
Average EPS Est. Cur. Y
-2.79
EPS Next Y. (Est.)
-2.54
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-112.58
Relative Volume
0.61
Return on Equity vs Sector %
-100
Return on Equity vs Industry %
-100
EPS 1 7Days Diff
EPS 1 30Days Diff
0.12
EBIT Estimation
◆
RGNX
Healthcare
$10.72
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
51.6
Range 1M
30.9%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
22.1%
52W%
49.1%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+147.2% upside
Upside
+147.2%
Quality
28
RGNX — P/E HistoricalBiotechnology
REGENXBIO Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 371
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202 for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 and with Nippon Shinyaku Co., Ltd. to develop RGX-121 and RGX-111 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.
RGNX
Latest News
—
Caricamento notizie per RGNX…
stock quote shares RGNX – REGENXBIO Inc. Stock Price stock today
news today RGNX – REGENXBIO Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RGNX – REGENXBIO Inc. yahoo finance google finance
stock history RGNX – REGENXBIO Inc. invest stock market
stock prices RGNX premarket after hours
ticker RGNX fair value insiders trading